Metro Healthcare Indonesia Tbk PT
IDX:CARE
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Price:
412
IDR
-2.37%
Market Cap:
13.7T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
CARE Alert
Metro Healthcare Indonesia Tbk PT
412
-10 (-2.37%)
| 52 Week Range |
174
422
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Metro Healthcare Indonesia Tbk PT
Metro Healthcare Indonesia Tbk PT
|
Revenue
|
315.9B
IDR
|
|
Cost of Revenue
|
-163.3B
IDR
|
|
Gross Profit
|
152.6B
IDR
|
|
Operating Expenses
|
-125.9B
IDR
|
|
Operating Income
|
26.7B
IDR
|
|
Other Expenses
|
-35.3B
IDR
|
|
Net Income
|
-8.6B
IDR
|
Income Statement
Metro Healthcare Indonesia Tbk PT
Metro Healthcare Indonesia Tbk PT
Currency: IDR
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
74 565
|
0
|
0
|
0
|
|
| Revenue |
216 296
N/A
|
234 686
+9%
|
258 201
+10%
|
289 799
+12%
|
290 934
+0%
|
278 751
-4%
|
257 336
-8%
|
230 153
-11%
|
260 426
+13%
|
219 589
-16%
|
216 489
-1%
|
213 825
-1%
|
242 681
+13%
|
277 238
+14%
|
312 948
+13%
|
328 677
+5%
|
319 022
-3%
|
315 185
-1%
|
311 611
-1%
|
315 902
+1%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(113 405)
|
(118 240)
|
(125 644)
|
(140 223)
|
(145 000)
|
(146 642)
|
(144 315)
|
(136 777)
|
(164 194)
|
(130 844)
|
(118 357)
|
(125 714)
|
(153 027)
|
(178 127)
|
(219 547)
|
(227 864)
|
(214 435)
|
(213 103)
|
(171 156)
|
(163 302)
|
|
| Gross Profit |
102 891
N/A
|
116 446
+13%
|
132 557
+14%
|
149 576
+13%
|
145 934
-2%
|
132 108
-9%
|
113 021
-14%
|
93 376
-17%
|
96 232
+3%
|
88 745
-8%
|
98 132
+11%
|
88 111
-10%
|
89 654
+2%
|
99 111
+11%
|
93 401
-6%
|
100 814
+8%
|
104 588
+4%
|
102 082
-2%
|
140 455
+38%
|
152 600
+9%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(118 409)
|
(123 933)
|
(127 268)
|
(133 997)
|
(131 836)
|
(138 521)
|
(145 264)
|
(148 225)
|
(156 824)
|
(150 703)
|
(135 923)
|
(135 751)
|
(125 793)
|
(126 284)
|
(133 501)
|
(128 681)
|
(134 515)
|
(142 642)
|
(131 996)
|
(125 883)
|
|
| Selling, General & Administrative |
(118 409)
|
(123 933)
|
(127 268)
|
(133 997)
|
(131 836)
|
(138 521)
|
(145 264)
|
(148 225)
|
(156 824)
|
(150 703)
|
(135 923)
|
(135 751)
|
(125 793)
|
(126 284)
|
(133 501)
|
(128 681)
|
(134 515)
|
(142 642)
|
(131 996)
|
(125 883)
|
|
| Operating Income |
(15 517)
N/A
|
(7 487)
+52%
|
5 288
N/A
|
15 578
+195%
|
14 098
-10%
|
(6 413)
N/A
|
(32 243)
-403%
|
(54 849)
-70%
|
(60 591)
-10%
|
(61 958)
-2%
|
(37 790)
+39%
|
(47 640)
-26%
|
(36 139)
+24%
|
(27 173)
+25%
|
(40 101)
-48%
|
(27 867)
+31%
|
(29 928)
-7%
|
(40 560)
-36%
|
8 460
N/A
|
26 717
+216%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
28 777
|
31 783
|
18 114
|
5 253
|
(10 057)
|
(22 547)
|
(33 548)
|
(41 908)
|
(58 361)
|
(67 173)
|
(68 788)
|
(81 096)
|
(70 234)
|
(68 180)
|
(71 696)
|
(64 799)
|
(68 323)
|
(66 974)
|
(62 370)
|
(65 698)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25 646
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23 448
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
0
|
0
|
0
|
72
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
533
|
733
|
697
|
3 225
|
2 465
|
2 404
|
1 888
|
(595)
|
(32)
|
25 931
|
26 552
|
26 526
|
178
|
96
|
1 194
|
8 718
|
(961)
|
23 566
|
23 338
|
34 305
|
|
| Pre-Tax Income |
13 793
N/A
|
25 029
+81%
|
24 099
-4%
|
24 057
0%
|
6 507
-73%
|
(26 556)
N/A
|
(63 902)
-141%
|
(97 352)
-52%
|
(93 316)
+4%
|
(103 199)
-11%
|
(80 027)
+22%
|
(102 209)
-28%
|
(106 123)
-4%
|
(95 257)
+10%
|
(110 603)
-16%
|
(83 948)
+24%
|
(75 764)
+10%
|
(83 967)
-11%
|
(30 572)
+64%
|
(4 676)
+85%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
375
|
(189)
|
(276)
|
(1 817)
|
(333)
|
1 285
|
2 248
|
4 546
|
(288)
|
(994)
|
(1 740)
|
(2 142)
|
(4 566)
|
(5 374)
|
(5 271)
|
(5 194)
|
(4 153)
|
(3 082)
|
(2 867)
|
(3 570)
|
|
| Income from Continuing Operations |
14 168
|
24 841
|
23 823
|
22 240
|
6 174
|
(25 271)
|
(61 655)
|
(92 806)
|
(93 604)
|
(104 193)
|
(81 766)
|
(104 351)
|
(110 689)
|
(100 631)
|
(115 874)
|
(89 142)
|
(79 917)
|
(87 049)
|
(33 439)
|
(8 246)
|
|
| Income to Minority Interest |
145
|
(12)
|
(77)
|
(282)
|
(74)
|
136
|
305
|
386
|
61
|
(9)
|
(177)
|
(262)
|
(231)
|
(277)
|
(277)
|
(244)
|
(392)
|
(183)
|
(235)
|
(351)
|
|
| Net Income (Common) |
14 313
N/A
|
24 829
+73%
|
23 746
-4%
|
21 958
-8%
|
6 099
-72%
|
(25 135)
N/A
|
(61 350)
-144%
|
(92 420)
-51%
|
(93 544)
-1%
|
(104 203)
-11%
|
(81 944)
+21%
|
(104 612)
-28%
|
(110 920)
-6%
|
(100 908)
+9%
|
(116 151)
-15%
|
(89 386)
+23%
|
(80 309)
+10%
|
(87 232)
-9%
|
(33 674)
+61%
|
(8 597)
+74%
|
|
| EPS (Diluted) |
0.43
N/A
|
0.74
+72%
|
0.71
-4%
|
0.66
-7%
|
0.18
-73%
|
-0.76
N/A
|
-1.85
-143%
|
-2.78
-50%
|
-2.81
-1%
|
-3.13
-11%
|
-2.46
+21%
|
-3.15
-28%
|
-3.34
-6%
|
-3.03
+9%
|
-3.49
-15%
|
-2.69
+23%
|
-2.42
+10%
|
-2.62
-8%
|
-1.01
+61%
|
-0.26
+74%
|
|
Switch to:
Switch to:
See Also
Discover More
